Consortia
Ingredient consortia bring together interested parties active in the consumer health sector, under a single management and budget, for the purpose of preparing and/or generating information to support the continued use of an ingredient in self-care products, notably in the context of risk assessment and market access procedures towards the European Commission or other European regulatory/scientific bodies.
Consortia at AESGP
Ingredient consortia managed by AESGP are open to all market operators (AESGP members as well as non-members) and are self-funded.
Information generated or acquired by a consortium is the property of the consortium members and is not, in principle, accessible to non-members of the consortium.
Membership is open throughout the life of the consortium, provided that a fair contribution to the accumulated costs is made. At any time, an interested market operator may apply to join a consortium as a late joiner.
Ongoing consortia
AESGP has initiated discussions in the pre-consortium phase for the following ingredients, with a focus on environmental risk assessment:
- Acetylsalicylic Acid
- Dextromethorphan
- Ibuprofen
- Paracetamol
- Pseudoephedrine
If you are interested, as a non-member, in joining any of the above pre-consortium discussions prior to the signing of the respective consortium agreement, please get in touch with us at consortia@aesgp.eu for further information.
AESGP Matchmaking Platform
Looking for the right partners to collaborate on ERA data generation? AESGP’s Matchmaking Platform makes it simple. By centralizing key information, the platform helps members connect efficiently, avoid duplication, and accelerate compliance efforts. Once introduced, members have full control to shape and manage their own pre-consortia.
Discover the platform